IRWD - Ironwood Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IRWD is currently covered by 2 analysts with an average price target of $5.59. This is a potential upside of $2.09 (59.71%) from yesterday's end of day stock price of $3.5.

Ironwood Pharmaceuticals's activity chart (see below) currently has 99 price targets and 83 ratings on display. The stock rating distribution of IRWD is 42.86% BUY and 57.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.91% with an average time for these price targets to be met of 214.46 days.

Highest price target for IRWD is $3, Lowest price target is $3, average price target is $3.

Most recent stock forecast was given by MOHIT BANSAL from WELLS FARGO on 11-Nov-2025. First documented stock forecast 11-Dec-2015.

Currently out of the existing stock ratings of IRWD, 3 are a BUY (42.86%), 4 are a HOLD (57.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

$-0.5 (-14.29%)

$1

18 days ago
(11-Nov-2025)

2/5 (40%)

$0.11 (3.81%)

61

Buy

$21

$17.5 (500.00%)

$19

1 years 9 months 13 days ago
(16-Feb-2024)

0/3 (0%)

$6.42 (44.03%)

Buy

$15

$11.5 (328.57%)

$15

3 years 2 months 27 days ago
(02-Sep-2022)

9/10 (90%)

$4.12 (37.87%)

630

Hold

$13

$9.5 (271.43%)

3 years 3 months 13 days ago
(16-Aug-2022)

1/2 (50%)

$0.99 (8.24%)

524

$14

$10.5 (300.00%)

4 years 1 months 17 days ago
(12-Oct-2021)

4/4 (100%)

$0.15 (1.08%)

259

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IRWD (Ironwood Pharmaceuticals) average time for price targets to be met?

On average it took 214.46 days on average for the stock forecasts to be realized with a an average price target met ratio 74.91

Which analyst has the current highest performing score on IRWD (Ironwood Pharmaceuticals) with a proven track record?

TIMOTHY CHIANG

Which analyst has the most public recommendations on IRWD (Ironwood Pharmaceuticals)?

Timothy Chiang works at CAPITAL ONE and has 4 price targets and 4 ratings on IRWD

Which analyst is the currently most bullish on IRWD (Ironwood Pharmaceuticals)?

David Amsellem with highest potential upside - $17.5

Which analyst is the currently most reserved on IRWD (Ironwood Pharmaceuticals)?

Mohit Bansal with lowest potential downside - -$0.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?